Soy, Isoflavones and Atherosclerosis View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2005

AUTHORS

R. St. Clair , M. Anthony

ABSTRACT

Consumption of soy protein is associated with a lower risk of cardiovascular disease in man, and reduced atherosclerosis in a variety of experimental animals. Although a portion of the cardiovascular protective effects appears to be due to reductions in plasma lipoprotein concentration, in most people the magnitude of this effect is relatively small. In many, but not all studies using animal models, the reduction in atherosclerosis is in part independent of changes in plasma lipids and lipoproteins. This implies that there may be a direct effect on the arterial wall of one or more of the components in soy protein that reduces susceptibility to atherosclerosis. The most actively studied components of soy protein that may be responsible for these anti-atherogenic effects are the isoflavones and various protein factions. Extraction of isoflavones and other alcohol-soluble components from soy protein lowers, but does not eliminate its ability to reduce atherosclerosis. Surprisingly, in most studies, adding back the isoflavone-rich alcohol extract to the previously extracted soy protein, or to another protein, does not restore its lipoprotein lowering or anti-atherogenic properties. This implies that alcohol extraction either destroys an active component of soy, alters the structural integrity of the soy proteins, or disassociates a required isoflavone—soy protein complex. Understanding the mechanism of this effect is an important goal for future research. Likewise, the sites of action on the arterial wall, and the mechanisms by 302 R. St. Clair and M. Anthony which various soy components act to reduce atherosclerosis are just now being studied. The recent demonstration that expression of estrogen receptor alpha is required for atheroprotection by soy protein provides important new mechanistic insight. Other properties of soy, including antioxidant, anti-inflammatory and potentially antithrombogenic properties need to be explored more mechanistically before the full potential of dietary soy protein for the protection from cardiovascular disease will be known. More... »

PAGES

301-323

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/3-540-27661-0_10

DOI

http://dx.doi.org/10.1007/3-540-27661-0_10

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1036685617

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/16596804


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antioxidants", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Atherosclerosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cardiovascular Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholesterol, LDL", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Inflammation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Isoflavones", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lipids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lipoproteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Soybean Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Soybeans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thrombosis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Section on Comparative Medicine, Wake Forest University School of Medicine, 27157, Winston-Salem, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.241167.7", 
          "name": [
            "Department of Pathology, Section on Comparative Medicine, Wake Forest University School of Medicine, 27157, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Clair", 
        "givenName": "R. St.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Section on Comparative Medicine, Wake Forest University School of Medicine, 27157, Winston-Salem, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.241167.7", 
          "name": [
            "Department of Pathology, Section on Comparative Medicine, Wake Forest University School of Medicine, 27157, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Anthony", 
        "givenName": "M.", 
        "id": "sg:person.01165514160.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165514160.38"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2005", 
    "datePublishedReg": "2005-01-01", 
    "description": "Consumption of soy protein is associated with a lower risk of cardiovascular disease in man, and reduced atherosclerosis in a variety of experimental animals. Although a portion of the cardiovascular protective effects appears to be due to reductions in plasma lipoprotein concentration, in most people the magnitude of this effect is relatively small. In many, but not all studies using animal models, the reduction in atherosclerosis is in part independent of changes in plasma lipids and lipoproteins. This implies that there may be a direct effect on the arterial wall of one or more of the components in soy protein that reduces susceptibility to atherosclerosis. The most actively studied components of soy protein that may be responsible for these anti-atherogenic effects are the isoflavones and various protein factions. Extraction of isoflavones and other alcohol-soluble components from soy protein lowers, but does not eliminate its ability to reduce atherosclerosis. Surprisingly, in most studies, adding back the isoflavone-rich alcohol extract to the previously extracted soy protein, or to another protein, does not restore its lipoprotein lowering or anti-atherogenic properties. This implies that alcohol extraction either destroys an active component of soy, alters the structural integrity of the soy proteins, or disassociates a required isoflavone\u2014soy protein complex. Understanding the mechanism of this effect is an important goal for future research. Likewise, the sites of action on the arterial wall, and the mechanisms by 302 R. St. Clair and M. Anthony which various soy components act to reduce atherosclerosis are just now being studied. The recent demonstration that expression of estrogen receptor alpha is required for atheroprotection by soy protein provides important new mechanistic insight. Other properties of soy, including antioxidant, anti-inflammatory and potentially antithrombogenic properties need to be explored more mechanistically before the full potential of dietary soy protein for the protection from cardiovascular disease will be known.", 
    "editor": [
      {
        "familyName": "von Eckardstein", 
        "givenName": "Arnold", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/3-540-27661-0_10", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-540-22569-0", 
        "978-3-540-27661-6"
      ], 
      "name": "Atherosclerosis: Diet and Drugs", 
      "type": "Book"
    }, 
    "keywords": [
      "cardiovascular disease", 
      "anti-atherogenic effects", 
      "arterial wall", 
      "anti-atherogenic properties", 
      "dietary soy protein", 
      "cardiovascular protective effects", 
      "plasma lipoprotein concentrations", 
      "estrogen receptor alpha", 
      "plasma lipids", 
      "lipoprotein concentrations", 
      "site of action", 
      "protective effect", 
      "lower risk", 
      "soy protein", 
      "animal models", 
      "atherosclerosis", 
      "receptor alpha", 
      "soy components", 
      "experimental animals", 
      "alcohol extract", 
      "disease", 
      "new mechanistic insights", 
      "protein factions", 
      "direct effect", 
      "isoflavones", 
      "alcohol-soluble components", 
      "most studies", 
      "soy", 
      "antithrombogenic properties", 
      "important new mechanistic insights", 
      "recent demonstration", 
      "atheroprotection", 
      "active components", 
      "protein", 
      "lipoproteins", 
      "effect", 
      "men", 
      "most people", 
      "risk", 
      "mechanistic insights", 
      "study", 
      "animals", 
      "alpha", 
      "reduction", 
      "important goal", 
      "future research", 
      "susceptibility", 
      "mechanism", 
      "expression", 
      "alters", 
      "lipids", 
      "wall", 
      "action", 
      "extracts", 
      "lowering", 
      "protection", 
      "people", 
      "changes", 
      "concentration", 
      "components", 
      "structural integrity", 
      "alcohol extraction", 
      "ability", 
      "demonstration", 
      "portion", 
      "integrity", 
      "sites", 
      "consumption", 
      "potential", 
      "variety", 
      "goal", 
      "part", 
      "full potential", 
      "research", 
      "extraction", 
      "insights", 
      "protein complexes", 
      "magnitude", 
      "model", 
      "complexes", 
      "properties", 
      "Lower", 
      "Anthony", 
      "extraction of isoflavones", 
      "factions", 
      "St. Clair", 
      "Clair", 
      "soy protein lowers", 
      "protein lowers", 
      "isoflavone-rich alcohol extract", 
      "lipoprotein lowering", 
      "isoflavone\u2014soy protein complex", 
      "properties of soy"
    ], 
    "name": "Soy, Isoflavones and Atherosclerosis", 
    "pagination": "301-323", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1036685617"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/3-540-27661-0_10"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "16596804"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/3-540-27661-0_10", 
      "https://app.dimensions.ai/details/publication/pub.1036685617"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2021-11-01T18:47", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/chapter/chapter_12.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/3-540-27661-0_10"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/3-540-27661-0_10'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/3-540-27661-0_10'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/3-540-27661-0_10'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/3-540-27661-0_10'


 

This table displays all metadata directly associated to this object as RDF triples.

219 TRIPLES      23 PREDICATES      134 URIs      127 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/3-540-27661-0_10 schema:about N1a8f32e27b1e4a2e86981072d996f146
2 N31243a41912e4eeaa2813b07133ba179
3 N40454390538d4c7b99f7e79bbffd5c66
4 N4e6750f34bdc423a91a6bff682c0f649
5 N6e06d00eb32c4fb99ab4811b0ce9c7f7
6 N8b2a017dd07f4ce890a8222458b40b68
7 N985e325684294b63af51e8e467639786
8 Nb597f27c39234f869deae4a68b9a2f94
9 Nbfdb85e02d334d9580ff68ce88f16bee
10 Nc449133a899a4d93aae20c31a9fe86d4
11 Nd7c42586e35e40ec916f8babbbe98808
12 Nd9159d182f6e482fb497da34521a4e69
13 Nea58c59f9b734b0fb9ff40009fd6196b
14 Nfa4f365dff3044f4a4bdac3016dbb44f
15 anzsrc-for:11
16 anzsrc-for:1102
17 schema:author Nc4109f46b6ab4e56b58f2bec0d721337
18 schema:datePublished 2005
19 schema:datePublishedReg 2005-01-01
20 schema:description Consumption of soy protein is associated with a lower risk of cardiovascular disease in man, and reduced atherosclerosis in a variety of experimental animals. Although a portion of the cardiovascular protective effects appears to be due to reductions in plasma lipoprotein concentration, in most people the magnitude of this effect is relatively small. In many, but not all studies using animal models, the reduction in atherosclerosis is in part independent of changes in plasma lipids and lipoproteins. This implies that there may be a direct effect on the arterial wall of one or more of the components in soy protein that reduces susceptibility to atherosclerosis. The most actively studied components of soy protein that may be responsible for these anti-atherogenic effects are the isoflavones and various protein factions. Extraction of isoflavones and other alcohol-soluble components from soy protein lowers, but does not eliminate its ability to reduce atherosclerosis. Surprisingly, in most studies, adding back the isoflavone-rich alcohol extract to the previously extracted soy protein, or to another protein, does not restore its lipoprotein lowering or anti-atherogenic properties. This implies that alcohol extraction either destroys an active component of soy, alters the structural integrity of the soy proteins, or disassociates a required isoflavone—soy protein complex. Understanding the mechanism of this effect is an important goal for future research. Likewise, the sites of action on the arterial wall, and the mechanisms by 302 R. St. Clair and M. Anthony which various soy components act to reduce atherosclerosis are just now being studied. The recent demonstration that expression of estrogen receptor alpha is required for atheroprotection by soy protein provides important new mechanistic insight. Other properties of soy, including antioxidant, anti-inflammatory and potentially antithrombogenic properties need to be explored more mechanistically before the full potential of dietary soy protein for the protection from cardiovascular disease will be known.
21 schema:editor N73a9277196b84df3929f8a4b80bf010d
22 schema:genre chapter
23 schema:inLanguage en
24 schema:isAccessibleForFree false
25 schema:isPartOf N72a4cedc315d45539f727adf486407fa
26 schema:keywords Anthony
27 Clair
28 Lower
29 St. Clair
30 ability
31 action
32 active components
33 alcohol extract
34 alcohol extraction
35 alcohol-soluble components
36 alpha
37 alters
38 animal models
39 animals
40 anti-atherogenic effects
41 anti-atherogenic properties
42 antithrombogenic properties
43 arterial wall
44 atheroprotection
45 atherosclerosis
46 cardiovascular disease
47 cardiovascular protective effects
48 changes
49 complexes
50 components
51 concentration
52 consumption
53 demonstration
54 dietary soy protein
55 direct effect
56 disease
57 effect
58 estrogen receptor alpha
59 experimental animals
60 expression
61 extraction
62 extraction of isoflavones
63 extracts
64 factions
65 full potential
66 future research
67 goal
68 important goal
69 important new mechanistic insights
70 insights
71 integrity
72 isoflavone-rich alcohol extract
73 isoflavones
74 isoflavone—soy protein complex
75 lipids
76 lipoprotein concentrations
77 lipoprotein lowering
78 lipoproteins
79 lower risk
80 lowering
81 magnitude
82 mechanism
83 mechanistic insights
84 men
85 model
86 most people
87 most studies
88 new mechanistic insights
89 part
90 people
91 plasma lipids
92 plasma lipoprotein concentrations
93 portion
94 potential
95 properties
96 properties of soy
97 protection
98 protective effect
99 protein
100 protein complexes
101 protein factions
102 protein lowers
103 recent demonstration
104 receptor alpha
105 reduction
106 research
107 risk
108 site of action
109 sites
110 soy
111 soy components
112 soy protein
113 soy protein lowers
114 structural integrity
115 study
116 susceptibility
117 variety
118 wall
119 schema:name Soy, Isoflavones and Atherosclerosis
120 schema:pagination 301-323
121 schema:productId Naa021a12eb014255bdb464bec5914f5b
122 Naad747f582ec4a39a43236fbce590151
123 Ne4260b015906412284eba5652146ddc6
124 schema:publisher Nc1ae11835ad14590adb21db94ffc7232
125 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036685617
126 https://doi.org/10.1007/3-540-27661-0_10
127 schema:sdDatePublished 2021-11-01T18:47
128 schema:sdLicense https://scigraph.springernature.com/explorer/license/
129 schema:sdPublisher Nafbc012cd4a64dfc9b0d1abafbbc599f
130 schema:url https://doi.org/10.1007/3-540-27661-0_10
131 sgo:license sg:explorer/license/
132 sgo:sdDataset chapters
133 rdf:type schema:Chapter
134 N1a8f32e27b1e4a2e86981072d996f146 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Soybean Proteins
136 rdf:type schema:DefinedTerm
137 N1ba8b302a872495e9afb5e4f3e98be56 schema:affiliation grid-institutes:grid.241167.7
138 schema:familyName Clair
139 schema:givenName R. St.
140 rdf:type schema:Person
141 N31243a41912e4eeaa2813b07133ba179 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Soybeans
143 rdf:type schema:DefinedTerm
144 N40454390538d4c7b99f7e79bbffd5c66 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Thrombosis
146 rdf:type schema:DefinedTerm
147 N4e6750f34bdc423a91a6bff682c0f649 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Humans
149 rdf:type schema:DefinedTerm
150 N6304025bbbf2407ab21f58b4acb4af09 rdf:first sg:person.01165514160.38
151 rdf:rest rdf:nil
152 N6e06d00eb32c4fb99ab4811b0ce9c7f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Atherosclerosis
154 rdf:type schema:DefinedTerm
155 N72a4cedc315d45539f727adf486407fa schema:isbn 978-3-540-22569-0
156 978-3-540-27661-6
157 schema:name Atherosclerosis: Diet and Drugs
158 rdf:type schema:Book
159 N73a9277196b84df3929f8a4b80bf010d rdf:first Nfac5bca0cb03466e875956f5ab978dad
160 rdf:rest rdf:nil
161 N8b2a017dd07f4ce890a8222458b40b68 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Cardiovascular Diseases
163 rdf:type schema:DefinedTerm
164 N985e325684294b63af51e8e467639786 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Blood Pressure
166 rdf:type schema:DefinedTerm
167 Naa021a12eb014255bdb464bec5914f5b schema:name dimensions_id
168 schema:value pub.1036685617
169 rdf:type schema:PropertyValue
170 Naad747f582ec4a39a43236fbce590151 schema:name doi
171 schema:value 10.1007/3-540-27661-0_10
172 rdf:type schema:PropertyValue
173 Nafbc012cd4a64dfc9b0d1abafbbc599f schema:name Springer Nature - SN SciGraph project
174 rdf:type schema:Organization
175 Nb597f27c39234f869deae4a68b9a2f94 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Isoflavones
177 rdf:type schema:DefinedTerm
178 Nbfdb85e02d334d9580ff68ce88f16bee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Lipoproteins
180 rdf:type schema:DefinedTerm
181 Nc1ae11835ad14590adb21db94ffc7232 schema:name Springer Nature
182 rdf:type schema:Organisation
183 Nc4109f46b6ab4e56b58f2bec0d721337 rdf:first N1ba8b302a872495e9afb5e4f3e98be56
184 rdf:rest N6304025bbbf2407ab21f58b4acb4af09
185 Nc449133a899a4d93aae20c31a9fe86d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Cholesterol, LDL
187 rdf:type schema:DefinedTerm
188 Nd7c42586e35e40ec916f8babbbe98808 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Antioxidants
190 rdf:type schema:DefinedTerm
191 Nd9159d182f6e482fb497da34521a4e69 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Inflammation
193 rdf:type schema:DefinedTerm
194 Ne4260b015906412284eba5652146ddc6 schema:name pubmed_id
195 schema:value 16596804
196 rdf:type schema:PropertyValue
197 Nea58c59f9b734b0fb9ff40009fd6196b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Lipids
199 rdf:type schema:DefinedTerm
200 Nfa4f365dff3044f4a4bdac3016dbb44f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Animals
202 rdf:type schema:DefinedTerm
203 Nfac5bca0cb03466e875956f5ab978dad schema:familyName von Eckardstein
204 schema:givenName Arnold
205 rdf:type schema:Person
206 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
207 schema:name Medical and Health Sciences
208 rdf:type schema:DefinedTerm
209 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
210 schema:name Cardiorespiratory Medicine and Haematology
211 rdf:type schema:DefinedTerm
212 sg:person.01165514160.38 schema:affiliation grid-institutes:grid.241167.7
213 schema:familyName Anthony
214 schema:givenName M.
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165514160.38
216 rdf:type schema:Person
217 grid-institutes:grid.241167.7 schema:alternateName Department of Pathology, Section on Comparative Medicine, Wake Forest University School of Medicine, 27157, Winston-Salem, NC, USA
218 schema:name Department of Pathology, Section on Comparative Medicine, Wake Forest University School of Medicine, 27157, Winston-Salem, NC, USA
219 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...